The additional value of PET/CT over PET in FDG imaging of oesophageal cancer
- 19 April 2005
- journal article
- clinical trial
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 32 (8) , 918-924
- https://doi.org/10.1007/s00259-005-1795-y
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Systematic Review of the Staging Performance of18F-Fluorodeoxyglucose Positron Emission Tomography in Esophageal CancerJournal of Clinical Oncology, 2004
- Neoplasms of the esophagus and stomachSeminars in Nuclear Medicine, 2004
- Head and Neck Cancer: Clinical Usefulness and Accuracy of PET/CT Image FusionRadiology, 2004
- FDG-PET/CT in re-staging of patients with lymphomaEuropean Journal of Nuclear Medicine and Molecular Imaging, 2003
- Pitfalls of Positive Findings in Staging Esophageal Cancer With F-18-Fluorodeoxyglucose Positron Emission TomographyAnnals of Surgical Oncology, 2003
- Staging of Non–Small-Cell Lung Cancer with Integrated Positron-Emission Tomography and Computed TomographyNew England Journal of Medicine, 2003
- Metastasis to Regional Lymph Nodes in Patients with Esophageal Squamous Cell Carcinoma: CT versus FDG PET for Presurgical Detection— Prospective StudyRadiology, 2003
- FDG-PET in Esophageal Cancer Incremental Value over Computed TomographyClinical Positron Imaging, 1999
- Correlation of CT with histopathological findings in patients with gastric and gastro-oesophageal carcinomas following neoadjuvant chemotherapyClinical Radiology, 1998
- Preoperative staging of esophageal cancer: comparison of endoscopic US and dynamic CT.Radiology, 1991